376 related articles for article (PubMed ID: 18241756)
1. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
2. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: A case report and plan for management.
Thakur S; Pigott JP; Comerota AJ
J Vasc Surg; 2009 Apr; 49(4):1037-40. PubMed ID: 19341891
[TBL] [Abstract][Full Text] [Related]
4. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
5. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
6. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
[TBL] [Abstract][Full Text] [Related]
7. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
8. Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model.
van der Steenhoven TJ; Bosman WM; Tersteeg C; Jacobs MJ; Moll FL; de Groot PG; Heyligers JM
Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):675-80. PubMed ID: 22436262
[TBL] [Abstract][Full Text] [Related]
9. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
10. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft.
Wheatcroft MD; Greco E; Tse L; Roche-Nagle G
Vascular; 2011 Dec; 19(6):338-41. PubMed ID: 22008977
[TBL] [Abstract][Full Text] [Related]
12. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results.
Bosiers M; Deloose K; Verbist J; Schroë H; Lauwers G; Lansink W; Peeters P
J Vasc Surg; 2006 Feb; 43(2):313-8; discussion 318-9. PubMed ID: 16476607
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.
Kasirajan K
Ann Vasc Surg; 2012 Aug; 26(6):802-8. PubMed ID: 22717356
[TBL] [Abstract][Full Text] [Related]
14. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
[TBL] [Abstract][Full Text] [Related]
15. Preservation of Heparin-Bonded Prosthetic Graft for Hemodialysis in the Setting of Early Heparin-Induced Thrombocytopenia.
Levin SR; Farber A; Siracuse JJ
Ann Vasc Surg; 2020 May; 65():282.e1-282.e3. PubMed ID: 31904512
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
17. Risk of heparin-induced thrombocytopenia from heparin-bonded vascular prostheses.
Mureebe L; Graham JA; Bush RL; Silver D
Ann Vasc Surg; 2007 Nov; 21(6):719-22. PubMed ID: 17980795
[TBL] [Abstract][Full Text] [Related]
18. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
20. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results.
Walluscheck KP; Bierkandt S; Brandt M; Cremer J
J Cardiovasc Surg (Torino); 2005 Aug; 46(4):425-30. PubMed ID: 16160689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
